Three patients in the severe COVID-19 group demonstrated strongly neutralizing anti-IFN-α AAbs, with titers exceeding 20,000 ng/mL, IC50 values ranging from 5000 to 68,000, and inhibition of IFN-α-induced STAT1 phosphorylation as assessed by flow cytometry. The gene discussed is STAT1; the disease is COVID-19.